Literature DB >> 26597283

What Is the Plural of a 'Yellow' Anecdote?

Stephen J W Evans1.   

Abstract

Mesh：

Year:  2016        PMID： 26597283     DOI： 10.1007/s40264-015-0368-7

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  13 in total

1.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Authors:  S J Evans; P C Waller; S Davis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Oct-Nov       Impact factor: 2.890

Review 2.  The reporting odds ratio and its advantages over the proportional reporting ratio.

Authors:  Kenneth J Rothman; Stephan Lanes; Susan T Sacks
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-08       Impact factor: 2.890

3.  An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies.

Authors:  Miguel-Angel Maciá-Martínez; Francisco J de Abajo; Gilly Roberts; Jim Slattery; Bharat Thakrar; Antoni F Z Wisniewski
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

4.  Let's Not Put All Our Eggs in One Basket.

Authors:  David J Hunter; Ralph B D'Agostino
Journal:  N Engl J Med       Date:  2015-08-20       Impact factor: 91.245

5.  Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.

Authors:  Jeffrey K Aronson
Journal:  J Eval Clin Pract       Date:  2005-04       Impact factor: 2.431

6.  Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.

Authors:  Patrick Waller; Emma Heeley; Jane Moseley
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK Medicines and Healthcare products Regulatory Agency.

Authors:  Suzie Seabroke; Lesley Wise; Patrick Waller
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

8.  Comparison of statistical signal detection methods within and across spontaneous reporting databases.

Authors:  Gianmario Candore; Kristina Juhlin; Katrin Manlik; Bharat Thakrar; Naashika Quarcoo; Suzie Seabroke; Antoni Wisniewski; Jim Slattery
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

Review 9.  Novel statistical tools for monitoring the safety of marketed drugs.

Authors:  J S Almenoff; E N Pattishall; T G Gibbs; W DuMouchel; S J W Evans; N Yuen
Journal:  Clin Pharmacol Ther       Date:  2007-05-30       Impact factor: 6.875

Review 10.  Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240
View more
  3 in total

1.  Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance.

Authors:  Manfred Hauben; Eric Y Hung
Journal:  Ther Adv Drug Saf       Date:  2016-05-23

2.  Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials.

Authors:  Raphaelle Beau-Lejdstrom; Sarah Crook; Alessandra Spanu; Tsung Yu; Milo A Puhan
Journal:  Pharmaceut Med       Date:  2019-08

3.  Good Signal Detection Practices: Evidence from IMI PROTECT.

Authors:  Antoni F Z Wisniewski; Andrew Bate; Cedric Bousquet; Andreas Brueckner; Gianmario Candore; Kristina Juhlin; Miguel A Macia-Martinez; Katrin Manlik; Naashika Quarcoo; Suzie Seabroke; Jim Slattery; Harry Southworth; Bharat Thakrar; Phil Tregunno; Lionel Van Holle; Michael Kayser; G Niklas Norén
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.